NCT03369912View on ClinicalTrials.gov

A Study to Evaluate CSJ148 in Pregnant Women With Primary HCMV Infection

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 23, 2018

Primary Completion Date

November 15, 2022

Study Completion Date

November 15, 2022

Conditions
HCMV Infection
Interventions
BIOLOGICAL

CSJ148

Active

OTHER

Placebo

No Drug

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY